Cibus (CBUS) vs NRX Pharmaceuticals (NRXP)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Cibus (CBUS) has outperformed NRX Pharmaceuticals (NRXP) over the past year, gaining 8.2% versus a loss of 19.3%. Over five years, NRXP leads with a -97.2% price change compared with -98.9% for CBUS. NRX Pharmaceuticals is the larger company by market cap ($125.1 million vs $121.5 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CBUS | NRXP |
|---|---|---|
| Share price | $1.59 | $2.89 |
| Market cap | $121.52M | $125.12M |
| 1-day change | -1.85% | -0.34% |
| YTD return | -8.62% | +6.64% |
| 1-year return | +8.16% | -19.27% |
| 5-year return | -98.92% | -97.18% |
| EPS (TTM) | $-1.60 | $-0.58 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.19 | $5.06 |
| 52-week low | $1.09 | $1.62 |
| Distance from 52-week high | -62.06% | -42.83% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +801.26% | +1232.18% |
| Average volume | 195.29K | 865.49K |
| Shares outstanding | 76.43M | 43.30M |
| Employees | 118 | 29 |
| Sector | Industrials | Health Care |
| Industry | Agricultural Chemicals | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CBUS has outperformed NRXP by 27.4 percentage points over the past year.
- The two companies sit in different sectors: Cibus in Industrials and NRX Pharmaceuticals in Health Care.
About Cibus
CBUS stock →Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits.
Industrials · Agricultural Chemicals · 118 employees
About NRX Pharmaceuticals
NRXP stock →NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder (PTSD), and schizophrenia in the United States. It operates through NRx and Dura segments.
Health Care · Biotechnology: Pharmaceutical Preparations · 29 employees
CBUS vs NRXP FAQ
Which is bigger, Cibus or NRX Pharmaceuticals?
NRX Pharmaceuticals (NRXP) is larger, with a market capitalization of $125.12M compared with $121.52M for Cibus (CBUS).
Which stock has performed better over the past year, CBUS or NRXP?
CBUS returned +8.16% over the past 12 months, compared with -19.27% for NRXP (price return, excluding dividends). Past performance does not predict future results.
Are Cibus and NRX Pharmaceuticals in the same industry?
No. Cibus is in the Industrials sector, while NRX Pharmaceuticals is in Health Care.